<DOC>
<DOCNO>EP-0620221</DOCNO> 
<TEXT>
<INVENTION-TITLE>
5-Acylamino-1,2,4-thiadiazoles as cholecystokinine antagonists or agonists.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3141	A61K3141	A61K31415	A61K31415	A61K31433	A61K31433	A61K3147	A61K3147	A61K31472	A61K314725	A61K31475	A61K31475	A61P100	A61P100	A61P104	A61P114	A61P116	A61P300	A61P304	A61P2500	A61P2500	A61P2504	A61P2520	A61P4300	A61P4300	C07D28500	C07D28508	C07D41700	C07D41712	C07D41714	C07D47100	C07D47106	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P1	A61P1	A61P1	A61P1	A61P1	A61P3	A61P3	A61P25	A61P25	A61P25	A61P25	A61P43	A61P43	C07D285	C07D285	C07D417	C07D417	C07D417	C07D471	C07D471	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to the thiadiazole derivatives corresponding to the general formula 
<
IMAGE
>
 in which Ar represents a nitrogenous aromatic heterocycle, especially indolyl which is unsubstituted or substituted on the nitrogen by CO-(C1-C4)alkyl; by (CH2)nCOR in which n represents 1 or 2 and R represents OR1 or NR1R2 with R1 and R2, which may or may not be identical, representing H or (C1-C4)alkyl; by C1 to C4 hydroxyalkyl; by C2 to C6 alkoxyalkyl; tetrahydropyranyl; or by a -(CH2)3-chain, the last carbon of which is attached to the phenyl ring of the indole to form a 6-membered ring;  Z represents:     (a) the group 
<
IMAGE
>
 where A and B, independently of one another, represent C, CH or N; and X1, X2, X3 and X4, which may or may not be identical, represent H, (C1-C3)alkyl, (C1-C3)alkoxy, Cl, Br or trifluoromethyl, or else   (b) an optionally substituted naphthyl group, and to their pharmaceutically acceptable salts.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
</TEXT>
</DOC>
